Amerika Serikat - Inggris - NLM (National Library of Medicine)

remedyrepack inc. - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg - concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions: drug interactions.) nifedipine must not be used in cases of cardiogenic shock. nifedipine is contraindicated in patients with a known hypersensitivity to any component of the tablet.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - nifedipine, quantity: 60 mg - tablet, modified release - excipient ingredients: iron oxide red; titanium dioxide; hypromellose; magnesium stearate; povidone; purified talc; macrogol 4000; carbomer 934p; lactose monohydrate; colloidal anhydrous silica; basic butylated methacrylate copolymer - treatment of hypertension. prophylaxis of chronic stable angina pectoris.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - nifedipine, quantity: 30 mg - tablet, modified release - excipient ingredients: carbomer 934p; titanium dioxide; povidone; purified talc; iron oxide red; macrogol 4000; hypromellose; magnesium stearate; colloidal anhydrous silica; lactose monohydrate; basic butylated methacrylate copolymer - treatment of hypertension. prophylaxis of chronic stable angina pectoris.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

state of florida doh central pharmacy - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg - nifedipine extended-release tablets, usp are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions , drug interactions . ) nifedipine must not be used in cases of cardiogenic shock. nifedipine is contraindicated in patients with a known hypersensitivity to any component of the tablet.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

viatris limited - atenolol 100mg; atenolol 100mg - film coated tablet - 100 mg - active: atenolol 100mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc sodium laurilsulfate sodium starch glycolate sunset yellow aluminium lake titanium dioxide active: atenolol 100mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc purified water sodium laurilsulfate sodium starch glycolate titanium dioxide - control of hypertension.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

viatris limited - atenolol 50mg; atenolol 50mg - film coated tablet - 50 mg - active: atenolol 50mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc sodium laurilsulfate sodium starch glycolate sunset yellow aluminium lake titanium dioxide active: atenolol 50mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc purified water sodium laurilsulfate sodium starch glycolate titanium dioxide - control of hypertension.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - atenolol -

Amerika Serikat - Inggris - NLM (National Library of Medicine)

rebel distributors corp - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 60 mg - nifedipine extended-release tablet is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by st segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. in those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. nifedipine extended-release tablet may also be used where the clinical presentation suggests a possible vasospastic component but where vasospasm has not been confirmed, e.g., where pain has a variable threshold on exertion or in unstable angina where electrocardiographic findings are compatible with intermittent vasospasm, or when angina is refractory to nitrates and/or adequate doses of beta-blockers. nifedipine extended-release tablet is indicated for the management of chronic stab

Amerika Serikat - Inggris - NLM (National Library of Medicine)

legacy pharmaceutical packaging, llc - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg - nifedipine extended-release tablet is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by st segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. in those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. nifedipine extended-release tablet may also be used where the clinical presentation suggests a possible vasospastic component, but where vasospasm has not been confirmed, e.g., where pain has a variable threshold on exertion, or in unstable angina where electrocardiographic findings are compatible with intermittent vasospasm, or when angina is refractory to nitrates and/or adequate doses of beta-blockers. nifedipine extended-release tablet is indicated for the management of chronic st

Amerika Serikat - Inggris - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 60 mg - nifedipine extended-release tablets are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions: drug interactions. ) nifedipine must not be used in cases of cardiogenic shock. nifedipine extended-release tablets are contraindicated in patients with a known hypersensitivity to any component of the tablet. the safety and effectiveness of nifedipine in pediatric patients have not been established. although small pharmacokinetic studies have identified an increased half-life and increased cmax and auc (see clinical pharmacology: pharmacokinetics and metabolism ), clinical studies of nifedipine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not ide